Clinical trial treatment of intestinal failure and parenteral nutrition associated liver disease using an omega-3 fatty acid (fish oil) based intravenous fat emulsion, OMEGAVE
Not Applicable
- Conditions
- intestinal failure and parenteral nutrition associated liver disease
- Registration Number
- JPRN-UMIN000001914
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Patient (parent or guardian of child) unwilling to provide consent or assent Inability or unwillingness on the part of parent/guardian or child to follow clinical recommendations of the Intestinal Rehabilitation Program Allergies or clinical conditions precluding safe use of Omegaven
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method resolution of parenteral nutrition associated liver disease ( PNALD) as measured by normalization of serum levels of hepatic enzymes and bilirubin. optimization of nutrition status
- Secondary Outcome Measures
Name Time Method progression to liver/intestinal transplant, death from liver failure